• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Video

July 9, 2022

Trends in Treatment, Management of Diabetes for Pharmacists

Conference|McKesson IdeaShare

The future trend in managing diabetes will extend into glycemic control, weight reduction, and renal liver, for example.

Pharmacy Times spoke with Susan Cornell, PharmD, Associate Director, OEE at Midwestern University College of Pharmacy, about her session at McKesson ideaShare 2022, titled "Diabetes Updates, Guidelines, and Trends."

Cornell: It changed this year and I'm very pleased with it. I've been predicting that Metformin would no longer be first line therapy for the past probably 5 to 6 years. You know, and finally, I can say Metformin is no longer considered our only choice for first line therapy to treat diabetes. And today, we have so many better options. You know, going back to what I said earlier, where we just can't look at just sugar, we have to look beyond sugar, cardiovascular, renal, liver weight, hypoglycemic risk. So these are things we have to look at. And unfortunately, Metformin doesn't hit those targets. You know, Metformin is great at lowering sugar, fasting sugar, but that's it. And, you know, again, good drug, it was the best thing in its day; but like me, it's getting older, and you know, maybe it's time for Metformin to retire at this point. So one of the things we have to look at is, what therapies do we have now that are approved and can be used first line? And of course, based on the new guidelines, we know that SGLT-2 inhibitors, as well as the injectable GLP-1 agonist can actually be an alternative, primarily looking at the ones that have a label indication for cardiovascular benefit. So I think that's important to note. So it's not all SGLT-2s, it's not all GLP-1 agonists, it's the ones that have a labeling for cardiovascular heart failure, or kidney disease benefit. And those are where we're looking to see potentially first line therapy. And I believe a trend that pharmacists are going to see, and they should be very anxious to see this, and maybe even recommend this to patients, is the combination therapy of an SGLT-2 inhibitor with a GLP-1 agonist. So again, that combination is really, what I see is, the future trend in managing diabetes, because you just get much better…not only glycemic coverage, but cardiovascular, renal liver and weight reduction coverage from those drugs. So you combine the two together and in a way you're setting the patient up for success.

Related Videos
Happy elderly patient with medical health checkup with cardiologist or geriatric doctor. Senior old aging woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com
Related Content
Advertisement
Carefully Consider Optimal Timing of RSV Vaccination in Older Adults
May 13th 2025

Carefully Consider Optimal Timing of RSV Vaccination in Older Adults

Lisa Rosenberg, PharmD, BCGP
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Pills spilled on United States dollars | Image Credit: © RomanR - stock.adobe.com
May 13th 2025

President Trump Signs Executive Order Aiming to Lower Prescription Drug Costs by Up to 90%

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Focuses on medical shield icon with healthcare symbols like hospital, Health Insurance and Medical Care Concept. doctor, medicine, and emergency care - Image credit: Jim | stock.adobe.com
May 13th 2025

May 2025 Pharmacy Policy

Aislinn Antrim, Managing Editor
Pharmacist Spotlight: Juliana Chan, PharmD, FCCP, BCACP
May 13th 2025

Pharmacist Spotlight: Juliana Chan, PharmD, FCCP, BCACP

Juliana Chan, PharmD, FCCP, BCACP PT Staff
Related Content
Advertisement
Carefully Consider Optimal Timing of RSV Vaccination in Older Adults
May 13th 2025

Carefully Consider Optimal Timing of RSV Vaccination in Older Adults

Lisa Rosenberg, PharmD, BCGP
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Pills spilled on United States dollars | Image Credit: © RomanR - stock.adobe.com
May 13th 2025

President Trump Signs Executive Order Aiming to Lower Prescription Drug Costs by Up to 90%

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Focuses on medical shield icon with healthcare symbols like hospital, Health Insurance and Medical Care Concept. doctor, medicine, and emergency care - Image credit: Jim | stock.adobe.com
May 13th 2025

May 2025 Pharmacy Policy

Aislinn Antrim, Managing Editor
Pharmacist Spotlight: Juliana Chan, PharmD, FCCP, BCACP
May 13th 2025

Pharmacist Spotlight: Juliana Chan, PharmD, FCCP, BCACP

Juliana Chan, PharmD, FCCP, BCACP PT Staff
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.